- Home
- TLS vs FDMT Comparison
TLS vs FDMT Comparison
Compare TLS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLS
- FDMT
- Stock Information
- Founded
- TLS 1969
- FDMT 2013
- Country
- TLS United States
- FDMT United States
- Employees
- TLS N/A
- FDMT N/A
- Industry
- TLS EDP Services
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- TLS Technology
- FDMT Health Care
- Exchange
- TLS Nasdaq
- FDMT Nasdaq
- Market Cap
- TLS 249.0M
- FDMT 268.6M
- IPO Year
- TLS 2020
- FDMT 2020
- Fundamental
- Price
- TLS $3.32
- FDMT $4.67
- Analyst Decision
- TLS Buy
- FDMT Buy
- Analyst Count
- TLS 5
- FDMT 11
- Target Price
- TLS $4.50
- FDMT $41.70
- AVG Volume (30 Days)
- TLS 289.8K
- FDMT 1.1M
- Earning Date
- TLS 03-14-2025
- FDMT 02-27-2025
- Dividend Yield
- TLS N/A
- FDMT N/A
- EPS Growth
- TLS N/A
- FDMT N/A
- EPS
- TLS N/A
- FDMT N/A
- Revenue
- TLS $122,959,000.00
- FDMT $17,000.00
- Revenue This Year
- TLS N/A
- FDMT N/A
- Revenue Next Year
- TLS $38.31
- FDMT $159.49
- P/E Ratio
- TLS N/A
- FDMT N/A
- Revenue Growth
- TLS N/A
- FDMT N/A
- 52 Week Low
- TLS $1.89
- FDMT $4.48
- 52 Week High
- TLS $5.03
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- TLS 47.95
- FDMT 32.64
- Support Level
- TLS $3.22
- FDMT $4.68
- Resistance Level
- TLS $3.41
- FDMT $5.15
- Average True Range (ATR)
- TLS 0.18
- FDMT 0.41
- MACD
- TLS 0.00
- FDMT -0.05
- Stochastic Oscillator
- TLS 53.70
- FDMT 8.69
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.